Evaluate 503B Outsourced Compounding Partners

Wednesday, December 9 | 1:00-1:20PM ET

Event Information

Partnering with a 503B outsourced compounder is essential for many hospital pharmacies, but there are a variety of factors to weigh before choosing a vendor. In this webinar, Eric S. Kastango, MBA, RPh, FASHP, vice president and managing partner at Kastango Consulting, provides guidance to the pharmacy, including how to evaluate FDA 483s, what to look for when visiting an outsourced compounding facility, addressing drug shortages, and more.


Eric Kastango, MBA, RPh, FASHP

Eric S. Kastango, MBA, RPh, FASHP, is vice president and managing partner of the Kastango Consulting Group, a TRC Healthcare Company. He received his Bachelor of Science degree in pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Master of Business Administration degree from the University of Phoenix. Since 1980, he has practiced pharmacy in a number of practice settings, including hospitals, community, and home care, in a number of different of roles, including the Corporate Vice President of Pharmacy Services for Coram Healthcare Corporation.

Fields marked with (*) are mandatory.

Register today!
Which upcoming webinars would you like to register for?
- December 9, 2020
- January 22, 2021
- February 5, 2021

You must have a www.pppmag.com user account in order to register for this webinar. If you already have an account, please log in here. If you do not already have an account, registering for this webinar will create one.